Head-to-head · Cost-Efficiency Index
Unique Physique vs Embody
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Unique Physique
Shoppers comfortable inferring which drug they're buying from a dose ceiling rather than a named label.
Visit Unique PhysiqueEmbody
Shoppers comparing low headline prices, who should confirm the actual charge at checkout given the company's own pages disagree.
Visit EmbodyThe verdict
Unique Physique takes it, leading the Cost-Efficiency Index 62 to 59. Unique Physique is a Baton Rouge, LA-based telehealth clinic under Medical Director Reena John, DO, offering two no-contract monthly weight-management tiers $159 covering doses up to 2.5mg and $289 covering all injectable doses. Embody still earns a C — Shoppers comparing low headline prices, who should confirm the actual charge at checkout given the company's own pages disagree.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Unique Physique.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Unique Physique | Embody |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 59/100 |
| Semaglutide / mo | $159/mo (all doses, compounded) | Not disclosed |
| Tirzepatide / mo | $289/mo (all doses, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,908 | — |
| Tirzepatide / yr (modeled) | $3,468 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #216 | #221 |
Unique Physique
62/100Where the value is
- No-contract, single flat monthly price at each tier rather than a shifting per-dose ladder
- Named Medical Director with a real, checkable credential: Reena John, DO
- States it provides consultations via 'Licensed Clinicians in the Patient's State,' implying state-matched prescribers
The tradeoffs
- The pricing page never explicitly names semaglutide or tirzepatide — which drug each tier covers is inferred from the dose ceiling, not stated by the company
- No compounding pharmacy is named anywhere reached, unusual for a compounded-GLP-1 provider
Embody
59/100Where the value is
- Flat pricing stated not to rise with dose or across months on the same plan
- No membership fee and no long-term contract — cancel anytime
- Four named compounding pharmacies across four different states, reducing single-facility risk
The tradeoffs
- The company's own pages quote different prices for the same product — $79/$129 on the main domain vs. $69/$119 (crossed out from a much higher $299/$349) on its paid-traffic landing pages — with no way from the page content alone to know which a given customer will actually be charged
- The $299/$349 'original' prices used as strikethrough anchors on the funnel pages are not explained or substantiated anywhere on the main site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.